Claims
- 1. An enzymatic method for detecting coliform bacteria, in a liquid or liquefied sample comprising the steps of:
- a) concentrating the bacteria on a membrane filter;
- b) placing the membrane filter and the bacteria concentrated thereon on a growth medium containing nutrients to support propagation of the bacteria and an inducer for inducing a marker enzyme in the course of their growth and metabolism;
- c) preincubating the membrane filter and the bacteria concentrated thereon to form microcolonies of these bacteria on the membrane filter and to produce said marker enzyme; and
- d) making the microcolonies visible by means of luminescence, characterized in that said microcolonies are made visible by an enzyme assay comprising:
- removing the membrane filter from the growth medium after said preincubation step (c);
- treating the microcolonies on the membrane filter with a membrane permeabilizer and contacting them with a chemiluminogenic or fluorogenic substrate for said marker enzyme;
- incubating the microcolonies to allow cleavage of said substrate so as to produce a chemiluminescent or fluorescent product; and
- triggering light emission from the chemiluminescent or fluorescent product produced by the microcolonies.
- 2. The method according to claim 1, characterized in that after said preincubation step (c), the membrane filter is placed on an assay medium containing said membrane permeabilizer and said substrate.
- 3. The method according to claim l, wherein the membrane filter is more hydrophobic than cellulose ester filters.
- 4. A method according to claim 1, wherein the inducer is an inducer of .beta.-galactosidase and the fluorogenic substrate comprises a fluorogenic galacto-pyranoside.
- 5. A method according to claim 1, wherein the inducer is an inducer of .beta.-glucuronidase and the fluorogenic substrate comprises a fluorogenic glucuronide.
- 6. A method according to claim 1, wherein the inducer is an inducer of .beta.-galactosidase and the chemiluminogenic substrate comprises a chemiluminogenic galactopyranoside.
- 7. A method according to claim 1, wherein the inducer is an inducer of .beta.-glucuronidase and the chemiluminogenic substrate comprises a chemiluminogenic glucuronide.
- 8. The method according to claim 8, characterized in that the chemiluminescent product produced by cleavage of the chemiluminogenic substrate is chemically triggered by an accelerator solution containing a dilute solution of an organic base.
- 9. The method according to claim 10, wherein the membrane filter is more hydrophobic than cellulose ester filters.
- 10. The method according to claim 1, wherein the membrane perineabilizer comprises polymyxin B and/or colistin methanesulfonate.
- 11. The method according to claim 1, wherein said growth medium comprises mineral nutrients, a protein hydrolysate, and a sugar or a polyalcohol.
- 12. The growth medium for use in a method according to claim 1, comprising mineral nutrients, a protein hydrolysate, an inducer for inducing a marker enzyme in the course of growth and metabolism of coliform bacteria, and a sugar or a polyalcohol.
- 13. The growth medium according to claim 12, characterized in that said mineral nutrients comprise monoammonium phosphate, dipotassium hydrogen phosphate, sodium chloride and magnesium sulfate.
- 14. The growth medium according to claim 12, comprising inhibitors of non-coliform bacteria.
- 15. A method according to claim 1, characterized in that said inducer is an inducer of .beta.-galactosidase and detects faecal or total coliform bacteria.
- 16. A method according to claim 1, characterized in that said inducer is an inducer of .beta.-glucuronidase and detects E. coli.
- 17. A method according to claim 7, wherein the chemiluminescent product produced by cleavage of the chemiluminogenic substrate is chemically triggered by an accelerator solution containing a dilute solution of an organic base.
- 18. The method according to claim 17, wherein the membrane filter is more hydrophobic than cellulose ester filters and said accelerator solution consists mainly of a dilute solution of said organic base only.
- 19. A method according to claim 15, wherein the .beta.-galactosidase inducer is a compound selected from the group consisting of isopropyl-.beta.-D-thiogalactopyranoside and meliboise.
- 20. A method according to claim 16, wherein the .beta.-glucuronidase inducer is a compound selected from the group consisting of isopropyl-.beta.-D-thio-glucuronide, pnitrophenyl-.beta.-D-glucuronide, p-nitrophenyl-.beta.-D-glucuronide and o-nitro-phenyl-.beta.-D-glucuronide and methyl-.beta.-D-glucuronide.
- 21. The method according to claim 3, wherein the membrane filter comprises polyvinylidenedifluoride (PVDF).
- 22. The method according claim 4, wherein the fluorogenic galacto-pyranoside is a umbelliferyl-.beta.-D-galactopyranoside.
- 23. The method according to claim 22, wherein the umbelliferyl-.beta.-D-galactopyranoside is 4-trifluoromethyl-umbelliferyl-.beta.-D-galactopyranoside (TFMU-gal).
- 24. The method according to claim 5, wherein the fluorogenic glucuronide is an umbelliferyl-.beta.-D-glucuronide.
- 25. The method according to claim 24, wherein the umbelliferyl-.beta.-D-glucuronide is 4ethyl-umbelliferyl-.beta.-D-glucuronide (TFMUG).
- 26. The method according to claim 6, wherein the chemiluminogenic galactopyranoside is 3-(4-methoxyspiro(1,2-dioxetane-3,2'-tri-cyclo (3.3.1.1.sup.3.7)decan)-4-yl)phenyl-.beta.-D-galactopyranoside (AMPGD) or a derivative thereof.
- 27. The method according to claim 26, wherein the derivative of 4-methoxyspiro(1,2-dioxetane-3,2'-tri-cyclo (3.3.1.1.sup.3.7)decan)-4-yl)phenyl-.beta.-D-galactopyranoside is a chloro derivative.
- 28. The method according to claim 7, wherein the chemiluminogenic glucuronide is (3-(4methoxyspiro-(1,2-dioxetane-3,2'-(5'-chloro)-tricyclo(3.3.1.1.sup.3.7)decan)-4-yl)phenyl)-.beta.-D-glucuronide or a derivative thereof.
- 29. The method according to claim 8, wherein the organic base comprises piperidine.
- 30. The method according to claim 9, wherein the membrane filter comprises polyvinylidene-difluoride (PVDF) and said accelerator solution consists mainly of a dilute solution of said organic base.
- 31. The method according to claim 30, wherein the organic base comprises piperidine.
- 32. The method according to claim 11, wherein said growth medium comprises mineral nutrients, the protein hydrolysate tryptone, and either the sugar maltose or the polyalcohol mannitol.
- 33. A growth medium according to claim 12, comprising mineral nutrients, the protein hydrolysate tryptone, either an inducer of .beta.-galactosidase or an inducer of .beta.-glucuronidase, and either the sugar maltose or the polyalcohol mannitol.
- 34. A growth medium according to claim 14, wherein said inhibitors of non-coliform bacteria are selected from the group consisting of sodium dodecyl sulfate, bile salts and ccfsulodin.
- 35. A method according to claim 17, wherein the organic base comprises piperidine.
- 36. A method according to claim 18, wherein the membrane filter comprises polyvinylidenedifluoride (PVDF) and said organic base comprises piperidine.
Priority Claims (1)
Number |
Date |
Country |
Kind |
PCT/BE94/00083 |
Nov 1994 |
WOX |
|
RELATED APPLICATIONS
This application claims the priority of PCT Application No. PCT/BE95/00102/, filed Nov. 7, 1995, and PCT Application No. PCT/BE94/00083, filed Nov. 7, 1994, which are incorporated herein by reference.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/BE95/00102 |
11/7/1995 |
|
|
7/14/1997 |
7/14/1997 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO96/14431 |
5/17/1996 |
|
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
9614431 |
May 1996 |
WOX |
Non-Patent Literature Citations (2)
Entry |
Nelis et al; Proceedings of the Water Quality Tech. Conference AWWA; pp. 1663-1673; Nov. 1993. |
De Marie et al; J. of Clinical Microbiology; pp. 255-258, Aug. 1984. |